COM:ASCENDISPHARMA
Ascendis Pharma
- Stock
Last Close
122.64
22/11 21:00
Market Cap
7.78B
Beta: -
Volume Today
378.33K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 37.70M - | 103.04M 173.29% | 169.80M 64.79% | ||||||||
average payables | 3.74M - | 6.66M 78.29% | 10.73M 60.93% | 18.42M 71.77% | 21.75M 18.08% | 23.75M 9.19% | 24.83M 4.54% | 40.66M 63.73% | 80.22M 97.32% | 97.80M 21.91% | |
average receivables | 2.04M - | 2.28M 11.79% | 1.93M 15.52% | 2.02M 4.93% | 2.50M 23.82% | 4.02M 60.67% | 6.38M 58.61% | 15.27M 139.32% | 24.41M 59.88% | 40.70M 66.76% | |
book value per share | 2.70 - | 5.06 87.17% | 6.65 31.32% | 5.57 16.26% | 6.82 22.43% | 12.84 88.36% | 16.57 29.06% | 16.13 2.64% | 4.70 70.89% | -2.59 155.11% | |
capex per share | -0.02 - | -0.04 82.81% | -0.03 42.13% | -0.03 10.62% | -0.06 130.31% | -0.11 72.11% | -0.43 283.84% | -0.44 3.91% | -0.26 41.60% | -0.04 83.21% | |
capex to depreciation | -0.80 - | -1.86 131.72% | -0.99 46.69% | -1.28 29.16% | -3.01 134.72% | -0.77 74.37% | -2.28 195.76% | -1.57 30.97% | -0.81 48.76% | -0.13 84.00% | |
capex to operating cash flow | 0.02 - | 0.02 8.62% | 0.01 53.28% | 0.01 11.39% | 0.02 92.80% | 0.03 53.71% | 0.08 170.66% | 0.06 26.89% | 0.03 49.63% | 0.01 82.12% | |
capex to revenue | -0.03 - | -0.13 341.89% | -0.15 13.99% | -0.62 321.55% | -0.25 59.31% | -0.39 54.13% | -3.10 703.61% | -3.12 0.52% | -0.28 90.91% | -0.01 96.77% | |
cash per share | 2.96 - | 5.03 69.95% | 6.79 34.84% | 5.81 14.42% | 6.76 16.41% | 12.86 90.16% | 14.20 10.42% | 12.45 12.31% | 13.12 5.33% | 7.10 45.90% | |
days of inventory on hand | 7.81K - | 3.93K 49.70% | 1.72K 56.29% | ||||||||
days payables outstanding | 6.16K - | 3.04K 50.64% | 777.49 74.41% | ||||||||
days sales outstanding | 61.99 - | 98.29 58.54% | 132.10 34.40% | 566.82 329.09% | 90.72 83.99% | 147.72 62.82% | 385.53 160.99% | 1.09K 182.23% | 182.78 83.20% | 76.32 58.24% | |
debt to assets | 0.05 - | 0.09 73.48% | 0.10 3.06% | 0.47 382.21% | 0.78 67.28% | ||||||
debt to equity | 0.06 - | 0.11 78.82% | 0.12 8.32% | 1.93 1,525.18% | -4.42 329.06% | ||||||
dividend yield | 0.01 - | ||||||||||
earnings yield | -0.04 - | -0.08 125.09% | -0.13 63.99% | -0.11 17.43% | -0.06 47.99% | -0.04 34.77% | -0.06 60.01% | -0.06 2.39% | -0.09 54.24% | -0.08 17.43% | |
enterprise value | 214.40M - | 281.02M 31.07% | 328.09M 16.75% | 918.28M 179.89% | 1.97B 114.59% | 5.21B 164.62% | 6.44B 23.58% | 6.17B 4.33% | 6.48B 5.07% | 6.66B 2.89% | |
enterprise value over ebitda | -18.67 - | -6.81 63.51% | -4.55 33.22% | -8.36 83.70% | -13.12 57.02% | -24.03 83.11% | -19.59 18.45% | -14.55 25.73% | -12.28 15.59% | -15.21 23.82% | |
ev to operating cash flow | -11.65 - | -6.47 44.51% | -5.45 15.68% | -9.66 77.12% | -14.20 47.03% | -29.64 108.76% | -23.73 19.93% | -14.76 37.80% | -13.07 11.48% | -14.26 9.13% | |
ev to sales | 15.33 - | 34.62 125.77% | 71.23 105.77% | 600.19 742.60% | 186.24 68.97% | 389.86 109.34% | 926.81 137.73% | 792.62 14.48% | 126.58 84.03% | 24.99 80.26% | |
free cash flow per share | -1.11 - | -1.87 68.62% | -2.29 22.33% | -2.86 24.68% | -3.44 20.54% | -3.89 13.10% | -5.79 48.71% | -8.07 39.32% | -9.10 12.78% | -8.35 8.27% | |
free cash flow yield | -0.07 - | -0.11 56.25% | -0.12 7.75% | -0.09 27.95% | -0.06 27.05% | -0.03 50.16% | -0.04 34.77% | -0.07 60.73% | -0.08 17.12% | -0.07 7.90% | |
graham net net | 2.31 - | 4.62 100.25% | 6.33 36.94% | 5.16 18.54% | 5.86 13.74% | 11.24 91.61% | 11.52 2.55% | 9.78 15.09% | -0.11 101.16% | -7.56 6,545.59% | |
graham number | 5.89 - | 12.56 113.23% | 19.64 56.36% | 21.48 9.38% | 22.04 2.58% | 36.80 66.99% | 55.55 50.95% | 50.42 9.24% | 33.15 34.25% | 22.32 32.68% | |
income quality | 1.91 - | 1.32 30.71% | 0.88 33.46% | 0.77 12.62% | 1.07 39.00% | 0.81 24.36% | 0.65 19.68% | 1.09 67.99% | 0.85 21.94% | 0.97 14.21% | |
intangibles to total assets | 0.06 - | 0.03 55.48% | 0.02 30.67% | 0.02 9.91% | 0.01 33.86% | 0.01 52.87% | 0.01 12.98% | 0.00 16.72% | 0.00 8.83% | 0.01 20.81% | |
interest coverage | -749.31 - | -6.97K 830.30% | -14.58K 109.21% | -1.15K 92.12% | -1.22K 5.97% | -185.68 84.76% | -172.38 7.17% | -115.52 32.99% | -11.13 90.37% | -10.34 7.10% | |
interest debt per share | 0.00 - | 0.00 73.28% | 0.00 25.44% | 0.00 1,432.58% | 0.00 7.16% | 0.81 26,221.84% | 1.85 127.99% | 1.99 7.16% | 9.97 401.42% | 12.23 22.69% | |
inventory turnover | 0.05 - | 0.09 98.80% | 0.21 128.77% | ||||||||
invested capital | 0.06 - | 0.11 78.82% | 0.12 8.32% | 1.93 1,525.18% | -4.42 329.06% | ||||||
market cap | 264.57M - | 400.67M 51.44% | 508.41M 26.89% | 1.11B 119.04% | 2.25B 101.90% | 5.78B 156.89% | 6.94B 20.10% | 6.51B 6.20% | 6.41B 1.42% | 6.41B 0.02% | |
net current asset value | 40.30M - | 114.21M 183.39% | 170.50M 49.29% | 180.87M 6.08% | 253.99M 40.43% | 531.55M 109.28% | 599.05M 12.70% | 604.60M 0.93% | 97.08M 83.94% | -268.56M 376.64% | |
net debt to ebitda | 4.37 - | 2.90 33.60% | 2.50 13.79% | 1.78 28.90% | 1.85 4.07% | 2.59 39.83% | 1.50 42.11% | 0.81 46.21% | -0.12 114.97% | -0.58 376.97% | |
net income per share | -0.57 - | -1.39 142.90% | -2.58 86.17% | -3.68 42.88% | -3.17 14.06% | -4.69 48.04% | -8.28 76.56% | -7.00 15.39% | -10.40 48.52% | -8.55 17.76% | |
operating cash flow per share | -1.09 - | -1.83 68.30% | -2.27 23.87% | -2.83 24.84% | -3.38 19.46% | -3.78 11.98% | -5.36 41.81% | -7.63 42.13% | -8.84 15.94% | -8.30 6.08% | |
payables turnover | 0.06 - | 0.12 102.61% | 0.47 290.79% | ||||||||
receivables turnover | 5.89 - | 3.71 36.92% | 2.76 25.60% | 0.64 76.69% | 4.02 524.78% | 2.47 38.58% | 0.95 61.68% | 0.34 64.57% | 2.00 495.29% | 4.78 139.47% | |
research and ddevelopement to revenue | 1.41 - | 4.99 254.39% | 14.33 187.12% | 65.09 354.10% | 13.26 79.63% | 14.33 8.06% | 37.52 161.91% | 38.04 1.37% | 7.42 80.50% | 1.55 79.10% | |
return on tangible assets | -0.18 - | -0.26 46.62% | -0.37 43.07% | -0.60 62.63% | -0.41 30.94% | -0.32 21.47% | -0.43 32.82% | -0.36 17.40% | -0.54 51.30% | -0.59 9.07% | |
revenue per share | 0.83 - | 0.34 58.63% | 0.17 49.24% | 0.05 73.76% | 0.26 466.02% | 0.29 11.67% | 0.14 52.24% | 0.14 3.38% | 0.91 542.68% | 4.74 419.20% | |
roe | -0.21 - | -0.27 29.77% | -0.39 41.77% | -0.66 70.62% | -0.46 29.81% | -0.37 21.40% | -0.50 36.81% | -0.43 13.10% | -2.21 410.16% | 3.30 249.22% | |
roic | -0.24 - | -0.34 39.43% | -0.41 20.74% | -0.59 44.23% | -0.55 7.17% | -0.34 38.68% | -0.32 4.36% | -0.41 27.74% | -0.73 78.02% | -0.77 5.38% | |
sales general and administrative to revenue | 0.45 - | 1.16 158.48% | 2.50 115.35% | 8.81 252.81% | 2.37 73.13% | 3.62 53.04% | |||||
shareholders equity per share | 2.70 - | 5.06 87.17% | 6.65 31.32% | 5.57 16.26% | 6.82 22.43% | 12.84 88.36% | 16.57 29.06% | 16.13 2.64% | 4.70 70.89% | -2.59 155.11% | |
stock based compensation to revenue | 0.09 - | 0.21 131.60% | 1.59 653.25% | 6.35 299.24% | 1.86 70.73% | 2.80 50.90% | 7.65 172.85% | 8.59 12.36% | 1.25 85.40% | 0.25 80.07% | |
tangible asset value | 42.31M - | 116.83M 176.11% | 173.12M 48.17% | 183.72M 6.12% | 276.56M 50.53% | 593.62M 114.65% | 832.99M 40.32% | 878.36M 5.45% | 258.52M 70.57% | -150.12M 158.07% | |
tangible book value per share | 2.29 - | 4.92 114.46% | 6.52 32.57% | 5.36 17.76% | 6.73 25.59% | 12.76 89.62% | 16.46 28.93% | 16.04 2.55% | 4.61 71.25% | -2.67 157.85% | |
working capital | 40.30M - | 114.21M 183.39% | 170.50M 49.29% | 180.87M 6.08% | 253.99M 40.43% | 563.18M 121.73% | 687.33M 22.04% | 705.53M 2.65% | 752.20M 6.61% | 505.38M 32.81% |
All numbers in USD (except ratios and percentages)